| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |